Company intelligence / Profile preview

Automata

London, England, United Kingdomautomata.tech ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Automata has developed the LINQ platform—a modular system combining robotics and cloud-based software—to automate laboratory workflows in life sciences. Their solutions are used by leading institutions to increase throughput and reduce manual labor in genomic testing, cell biology research, diagnostics, and drug discovery. Customers report significant increases in throughput and reductions in manual interventions.

Modalities: DeviceSoftware platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

NHS Trusts UKImperial College LondonNovartisThe Francis Crick Institutebit.bio

Beyond the preview

Go deeper on Automata.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Automata.

Explore the full profile